Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces

AIDS

Volumn 21, Issue 2, 2007, Pages 145-151

  Plipat, Tanarak ^a   Naiwatanakul, Thananda ^a   Rattanasuporn, Niramon ^a   Sangwanloy, Orapan ^a   Amornwichet, Pornsinee ^a   Teeraratkul, Achara ^a   Ungchusak, Kumnuan ^a   Mock, Philip ^a   Levine, William ^b   McConnell, Michelle S ^a,b   Simonds, R J ^b   Culnane, Mary ^a,b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral therapy; HIV prevention; Monitoring and evaluation; Nevirapine; Thailand; Vertical HIV transmission; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ADD ON THERAPY; ARTICLE; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; SHORT COURSE THERAPY; THAILAND; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, VERTICAL; FEMALE; GOVERNMENT PROGRAMS; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; PROGRAM EVALUATION; THAILAND;

EID: 33845947198     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328010e02d     Document Type: Article

References (18)

1. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353:773-780.
2. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 343:982-991.
3. Kanshana S, Thewanda D, Teeraratkul A, Limpakarnjanarat K, Amornwichet P, Kullerk N, et al. Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large regional pilot program in northeastern Thailand. AIDS 2000; 14:1617-1623.
4. Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand. Southeast Asian J Trop Med Public Health 1998; 29:429-442.
5. Ministry of Public Health, Thailand. National guidelines for the clinical management of HIV infection in adults and children. 6th ed. Nonthaburi, Thailand: Ministry of Public Health; 2000.
6. Kanshana S, Simonds RJ. National program for preventing mother-child HIV transmission in Thailand - successful implementation and lessons learned. AIDS 2002; 16:953-959.
7. Amornwichet P, Teeraratkul A, Simonds RJ, Naiwatanakul T, Chantharojwong N, Culnane M, et al. Preventing mother-to-child HIV transmission: The first year of Thailand's national program. JAMA 2002; 288:245-248.
8. Health Information Unit, Bureau of Health Policy and Strategy, Ministry of Public Health and the Perinatal HIV Intervention Monitoring System, Department of Health, Ministry of Public Health, Nonthaburi, Thailand.
9. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1999; 41(RR-17):1-19.
10. ANRS 1201/1202 DITRAME PLUS Study Group. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005; 19:309-318.
11. Coetze D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull WHO 2005; 83:489-493.
12. Teeraratkul A, Simonds RJ, Asavapiriyanont S, Chalermchokcharoenkit A, Vanprapa N, Chotpitayasunondh T, et al. Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals. J Acquir Immune Defic Syndr 2005; 38:208-212.
13. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang N, Koetsawang S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351:217-228.
14. Thisyakorn U, Khongphatthanayothin M, Sirivichayakul S, Sirivichayakul S, Rongkavilit C, Poolcharoen W, et al. Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen. AIDS 2000; 18:2921-2927.
15. De Cock KM, Fowler MG, Mercier E, de Vincenzi L, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000; 283:1175-1183.
16. Shaffer N, Roongpisuthipong A, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young N, et al. Maternal viral load and perinatal HIV-1 subtype E transmission, Bangkok. Thailand J Infect Dis 1999; 179:590-599.
17. Chalermchokcharoenkit A, Asavapiriyanont S, Teeraratkul A, Chaowanachan T, Mock P, Wilasrusme P, et al. Combination short-sourse zidovudine plus 2-dose nevirapine for prevention of mother to child transmission: safety, tolerance, transmission and resistance results. Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February 2004 [abstract 96].
18. Anon. The Report of National Prevention of Mother to Child HIV Transmission Program, January 2001-December 2003. Nonthaburi, Thailand: Department of Health, Ministry of Public Health.